Full text is available at the source.
Abstract
Intestinal dysbiosis is suggested to play a critical role in Parkinson's Disease progression.
- Parkinson's Disease is associated with motor and non-motor symptoms.
- Pathophysiological mechanisms of PD include alpha-synuclein aggregation, mitochondrial dysfunction, neuroinflammation, and oxidative stress.
- Dysbiosis may impact intestinal barrier function and contribute to neurotransmitter deficiencies, including dopamine, serotonin, and GABA.
- Current treatments involve levodopa and dopamine agonists, alongside gut health therapies like probiotics and Fecal Microbiota Transplantation.
- Future therapeutic directions may include synbiotics, engineered microbes, phage therapy, and the use of machine learning and artificial intelligence.
- Preventive strategies may involve lifestyle adjustments and early monitoring of gut health.
Simplified